As a lawyer specialising in pharmaceutical and IP law, Manja has been advising pharmaceutical and biotechnology companies, medical device manufacturers, and food producers on all matters relating to intellectual property and regulatory questions for many years.

A focus of her practice involves advising clients on contractual projects of a complex and cross-border nature, in particular, research and development cooperations, manufacturing agreements, distribution agreements, licencing agreements, as well as providing advise on all matters relating to transactions.

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

Word on the street at the J.P. Morgan Healthcare Conference 2023

2023年2月1日

作者

点击此处了解更多
酒店与休闲

Long-running issue: the distinction between cosmetic products and medicinal products by function

2022年12月15日
Briefing

作者 Dr. Manja Epping 以及 Sherin Sayed

点击此处了解更多
酒店与休闲

Clinical trials on medicinal products for human use under the new EU Clinical Trials Regulation No. 536/2014 (“CTR”)

2022年9月21日
In-depth analysis

作者 Dr. Manja Epping 以及 Irina Rebin

点击此处了解更多
酒店与休闲

In-vitro Diagnostic Medical Devices under the new Regulation (EU) 2017/746

2022年9月20日
In-depth analysis

作者 Dr. Manja Epping 以及 Irina Rebin

点击此处了解更多

与我会面: